|
1）Sawzdargo M, George SR, et al. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem Biophys Res Commun. 1997; 239: 543-7
|
|
|
|
2）Chawla A, Repa JJ, et al. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001; 294: 1866-70
|
|
|
|
|
|
3）Hirasawa A, Tsumaya K, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005; 11: 90-4
|
|
|
|
|
|
4）Tanaka T, Katsuma S, et al. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharma-col. 2008; 377: 523-7
|
|
|
|
|
|
5）Matsumura S, Eguchi A, et al. Colocalization of GPR120 with phospholipase-Cbeta2 and alpha-gustducin in the taste bud cells in mice. Neurosci Lett. 2009; 450: 186-90
|
|
|
|
|
|
6）Cartoni C, Yasumatsu K, et al. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci. 2010; 30: 8376-82
|
|
|
|
|
|
7）Martin C, Passilly-Degrace P, et al. The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference. PLoS One. 2011; 6: e24014
|
|
|
|
|
|
8）Martin C, Passilly-Degrace P, et al. Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res. 2012; Aug 19: [Epub ahead of print]
|
|
|
|
|
|
9）Oh DY, Talukdar S, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010; 142: 687-98
|
|
|
|
|
|
10）Oh DY, Lagakos WS. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity. Curr Opin Clin Nutr Metab Care. 2011; 14: 322-7
|
|
|
|
|
|
11）Gotoh C, Hong YH, et al. The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun. 2007; 354: 591-7
|
|
|
|
|
|
12）Ichimura A, Hirasawa A, et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012; 483: 350-4
|
|
|
|
|
|
13）Itoh Y, Kawamata Y, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 2003; 422: 173-6
|
|
|
|
|
|
14）Edfalk S, Steneberg P, et al. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008; 57: 2280-7
|
|
|
|
|
|
15）Hara T, Hirasawa A, et al. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J Pharm Sci. 2011; 100: 3594-601
|
|
|
|
|
|
16）Hara T, Hirasawa A, et al. Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1). Mol Pharmacol. 2009; 75: 85-91
|
|
|
|
|
|
17）Takeuchi M, Hirasawa A, et al. FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models. Br J Pharmacol. 2012; May; [Epub ahead of print]
|
|
|
|
|
|
18）Burant CF, Viswanathan P, et al. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2012; 379: 1403-11
|
|
|
|
|
|
19）Brown AJ, Goldsworthy SM, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003; 278: 11312-9
|
|
|
|
|
|
20）Xiong Y, Miyamoto N, et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A. 2004; 101: 1045-50
|
|
|
|
|
|
21）Wu J, Zhou Z, et al. Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J Genet Genomics. 2012; 39: 375-84
|
|
|
|
|
|
22）Samuel BS, Shaito A, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008; 105: 16767-72
|
|
|
|
|
|
23）Kimura I, Inoue D, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A. 2011; 108: 8030-5
|
|
|
|
|
|
24）Tiwari A. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance. Curr Opin Investig Drugs. 2010; 11: 385-93
|
|
|
|
|
|
25）Karaki S, Tazoe H, et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008; 39: 135-42
|
|
|
|
|
|
26）Ge H, Li X, et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology. 2008; 149: 4519-26
|
|
|
|
|
|
27）Hong YH, Nishimura Y, et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 2005; 146: 5092-9
|
|
|
|
|
|
28）Tolhurst G, Heffron H, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012; 61: 364-71
|
|
|
|
|
|
29）Bindels LB, Porporato P, et al. Gut microbiota-derived propionate reduces cancer cell prolifera-tion in the liver. Br J Cancer. 2012; 107: 1337-44
|
|
|
|
|